158 related articles for article (PubMed ID: 38543811)
1. Immune System Deficiencies Do Not Alter SARS-CoV-2 Evolutionary Rate but Favour the Emergence of Mutations by Extending Viral Persistence.
Manuto L; Bado M; Cola M; Vanzo E; Antonello M; Mazzotti G; Pacenti M; Cordioli G; Sasset L; Cattelan AM; Toppo S; Lavezzo E
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543811
[TBL] [Abstract][Full Text] [Related]
2. Quasispecies Analysis of SARS-CoV-2 of 15 Different Lineages during the First Year of the Pandemic Prompts Scratching under the Surface of Consensus Genome Sequences.
Bader W; Delerce J; Aherfi S; La Scola B; Colson P
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555300
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.
Quaranta EG; Fusaro A; Giussani E; D'Amico V; Varotto M; Pagliari M; Giordani MT; Zoppelletto M; Merola F; Antico A; Stefanelli P; Terregino C; Monne I
Int J Infect Dis; 2022 Sep; 122():444-448. PubMed ID: 35724829
[TBL] [Abstract][Full Text] [Related]
4. Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispecies.
Lau BT; Pavlichin D; Hooker AC; Almeda A; Shin G; Chen J; Sahoo MK; Huang CH; Pinsky BA; Lee HJ; Ji HP
Genome Med; 2021 Apr; 13(1):62. PubMed ID: 33875001
[TBL] [Abstract][Full Text] [Related]
5. Effect of molnupiravir on SARS-CoV-2 evolution in immunocompromised patients: a retrospective observational study.
Fountain-Jones NM; Vanhaeften R; Williamson J; Maskell J; Chua IJ; Charleston M; Cooley L
Lancet Microbe; 2024 May; 5(5):e452-e458. PubMed ID: 38527471
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.
Sun F; Wang X; Tan S; Dan Y; Lu Y; Zhang J; Xu J; Tan Z; Xiang X; Zhou Y; He W; Wan X; Zhang W; Chen Y; Tan W; Deng G
Microbiol Spectr; 2021 Sep; 9(1):e0026121. PubMed ID: 34346744
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies.
Karamitros T; Papadopoulou G; Bousali M; Mexias A; Tsiodras S; Mentis A
J Clin Virol; 2020 Oct; 131():104585. PubMed ID: 32818852
[TBL] [Abstract][Full Text] [Related]
8. Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies.
Feng S; Reid GE; Clark NM; Harrington A; Uprichard SL; Baker SC
Virol J; 2024 May; 21(1):105. PubMed ID: 38715113
[TBL] [Abstract][Full Text] [Related]
9. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
[TBL] [Abstract][Full Text] [Related]
10. Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples.
Xiao M; Liu X; Ji J; Li M; Li J; Yang L; Sun W; Ren P; Yang G; Zhao J; Liang T; Ren H; Chen T; Zhong H; Song W; Wang Y; Deng Z; Zhao Y; Ou Z; Wang D; Cai J; Cheng X; Feng T; Wu H; Gong Y; Yang H; Wang J; Xu X; Zhu S; Chen F; Zhang Y; Chen W; Li Y; Li J
Genome Med; 2020 Jun; 12(1):57. PubMed ID: 32605661
[TBL] [Abstract][Full Text] [Related]
11. Evolution of viral quasispecies during SARS-CoV-2 infection.
Jary A; Leducq V; Malet I; Marot S; Klement-Frutos E; Teyssou E; Soulié C; Abdi B; Wirden M; Pourcher V; Caumes E; Calvez V; Burrel S; Marcelin AG; Boutolleau D
Clin Microbiol Infect; 2020 Nov; 26(11):1560.e1-1560.e4. PubMed ID: 32717416
[TBL] [Abstract][Full Text] [Related]
12. Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS-CoV-2 Infection in an Immunocompromised Patient.
Brandolini M; Zannoli S; Gatti G; Arfilli V; Cricca M; Dirani G; Denicolò A; Semprini S; Grumiro L; Imola M; Larne D; Marino MM; Manera M; Mancini A; Taddei F; Zagarrigo M; Biagetti C; Sambri V
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851504
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma.
Borges V; Isidro J; Cunha M; Cochicho D; Martins L; Banha L; Figueiredo M; Rebelo L; Trindade MC; Duarte S; Vieira L; Alves MJ; Costa I; Guiomar R; Santos M; Cortê-Real R; Dias A; Póvoas D; Cabo J; Figueiredo C; Manata MJ; Maltez F; Gomes da Silva M; Gomes JP
mSphere; 2021 Aug; 6(4):e0024421. PubMed ID: 34319130
[TBL] [Abstract][Full Text] [Related]
14. Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis.
Fournelle D; Mostefai F; Brunet-Ratnasingham E; Poujol R; Grenier JC; Gálvez JH; Pagliuzza A; Levade I; Moreira S; Benlarbi M; Beaudoin-Bussières G; Gendron-Lepage G; Bourassa C; Tauzin A; Grandjean Lapierre S; Chomont N; Finzi A; Kaufmann DE; Craig M; Hussin JG
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543708
[TBL] [Abstract][Full Text] [Related]
15. De novo emergence of SARS-CoV-2 spike mutations in immunosuppressed patients.
Simons LM; Ozer EA; Gambut S; Dean TJ; Zhang L; Bhimalli P; Schneider JR; Mamede JI; Ison MG; Karmali R; Gordon LI; Lorenzo-Redondo R; Hultquist JF
Transpl Infect Dis; 2022 Dec; 24(6):e13914. PubMed ID: 35899968
[TBL] [Abstract][Full Text] [Related]
16. Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host.
Sonnleitner ST; Prelog M; Sonnleitner S; Hinterbichler E; Halbfurter H; Kopecky DBC; Almanzar G; Koblmüller S; Sturmbauer C; Feist L; Horres R; Posch W; Walder G
Nat Commun; 2022 May; 13(1):2560. PubMed ID: 35538074
[TBL] [Abstract][Full Text] [Related]
17. "Outlaw" mutations in quasispecies of SARS-CoV-2 inhibit replication.
Colson P; Fantini J; Delerce J; Bader W; Levasseur A; Pontarotti P; Devaux C; Raoult D
Emerg Microbes Infect; 2024 Dec; 13(1):2368211. PubMed ID: 38916498
[TBL] [Abstract][Full Text] [Related]
18. Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies.
Vellas C; Del Bello A; Debard A; Steinmeyer Z; Tribaudeau L; Ranger N; Jeanne N; Martin-Blondel G; Delobel P; Kamar N; Izopet J
Clin Microbiol Infect; 2022 Jan; 28(1):139.e5-139.e8. PubMed ID: 34537363
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 evolution during prolonged infection in immunocompromised patients.
Marques AD; Graham-Wooten J; Fitzgerald AS; Sobel Leonard A; Cook EJ; Everett JK; Rodino KG; Moncla LH; Kelly BJ; Collman RG; Bushman FD
mBio; 2024 Mar; 15(3):e0011024. PubMed ID: 38364100
[TBL] [Abstract][Full Text] [Related]
20. Within-Host and Between-Host Evolution in SARS-CoV-2-New Variant's Source.
Moelling K
Viruses; 2021 Apr; 13(5):. PubMed ID: 33922936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
